Vertex Pharmaceuticals VRTX Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $2.99B-6.4% | $3.19B+3.7% | $3.08B+3.8% | $2.96B+7.0% | $2.77B-4.9% | ||
| $392.8M-15.7% | $466M+12.3% | $414.8M+1.8% | $407.5M+12.3% | $363M-14.3% | ||
| $2.59B-4.8% | $2.72B+2.3% | $2.66B+4.1% | $2.56B+6.2% | $2.41B-3.3% | ||
| 86.8%+1.5pp | 85.4%-1.1pp | 86.5%+0.3pp | 86.3%-0.6pp | 86.9%+1.4pp | ||
| $493.7M+1.4% | $487M+9.4% | $445.1M+4.8% | $424.6M+7.1% | $396.4M+5.0% | ||
| $1.85B-6.8% | $1.98B+5.0% | $1.89B+4.2% | $1.81B-15.3% | $2.14B+13.5% | ||
| $1.14B-5.6% | $1.21B+1.7% | $1.19B+3.0% | $1.15B+82.7% | $630.1M— | ||
| 38.1%+0.3pp | 37.8%-0.8pp | 38.6%-0.3pp | 38.8%+16.1pp | 22.7%— | ||
| $1.25B-5.9% | $1.33B+2.5% | $1.3B+1.2% | $1.28B+75.7% | $730.4M-35.7% | ||
| $221.5M+58.3% | $139.9M-35.2% | $215.9M-13.7% | $250.1M+197% | $84.1M-62.4% | ||
| $1.03B-13.4% | $1.19B+10.0% | $1.08B+4.8% | $1.03B+59.8% | $646.3M— | ||
| 34.5%-2.8pp | 37.3%+2.1pp | 35.2%+0.4pp | 34.8%+11.5pp | 23.3%— | ||
| $4.02-13.4% | $4.64+10.5% | $4.20+5.3% | $3.99+60.2% | $2.49— | ||
| $1.19B-5.4% | $1.26B+1.7% | $1.24B+3.1% | $1.2B+77.3% | $678.5M-42.8% | ||
| 40%+0.4pp | 39.5%-0.8pp | 40.3%-0.3pp | 40.6%+16.1pp | 24.5%-16.2pp | ||
| $1.14B-5.6% | $1.21B+1.7% | $1.19B+3.0% | $1.15B+82.7% | $630.1M-44.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Vertex Pharmaceuticals's revenue?
- Vertex Pharmaceuticals (VRTX) generated $12.2B in revenue over the trailing twelve months, up 10.1% year over year.
- Is Vertex Pharmaceuticals profitable?
- Vertex Pharmaceuticals reported $4.3B in net income over the trailing twelve months, a 35.5% net margin.
- What are Vertex Pharmaceuticals's profit margins?
- Gross margin is 86.2% and operating margin is 38.3%, with a 35.5% net margin.
- What is Vertex Pharmaceuticals's earnings per share?
- Vertex Pharmaceuticals's diluted EPS over the trailing twelve months is $16.85.
- Where does Vertex Pharmaceuticals's income statement data come from?
- Every line is extracted from Vertex Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
